Abstract
This chapter focuses on the commercial and management aspect of biotechnology’s business in today’s scenario. The recent trends and the developments in the business models of the biotech sector would be dealt in detail. The recent economy predicts the pharmaceutical sector as the most capital intensive market area but the challenges in taking up a career in biotechnology and ethical principles that govern the setting up of an industry in core areas of biotechnology are huge. The role of biotech industry in terms of commercial, industrial and economical grounds gains importance since it requires a lot of manpower in the intellectual and in the commercial front. A success story of a biotech sector involves a lot of challenges to be faced. Hence, the chapter would highlight the challenges that equip oneself to be an entrepreneur amidst the growing demands of the biotech sector. The chapter also throws light on the core and sub-domains of life science and biotech companies which have grown enormously in the past two decades.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Assa F, Jafarizadeh-Malmiri H, Ajamein H, Anarjan N, Vaghari H, Sayyar Z, Berenjian A (2016) A biotechnological perspective on the application of iron oxide nanoparticles. Nano Res 9(8):2203–2225
Cardon MS, Kirk CP (2015) Entrepreneurial passion as mediator of the self-efficacy to persistence relationship. Entrepreneurship Theory Pract 39(5):1027–1050
Chaudhary G, Singh SK (2019) Global status of genetically modified crops and its commercialization. In: Khoobchandani M, Saxena A (eds) Biotechnology products in everyday life. EcoProduction (Environmental Issues in Logistics and Manufacturing). Springer, Cham
Chok J, Sun Q (2007) Determinants of idiosyncratic volatility for biotech IPO firms. Financ Manag 36(4):107–122
Delangiz N, Varjovi MB, Lajayer BA et al (2019) Arab J Geosci 12:174
Dettenhofer M, Ondrejovič M, Slavica A, Kurtanjek Ž, Tapaloaga D, Rodian Tapaloaga P, Kapur Pojskić L, Durmić-Pašić A, Begović J, Nedović V, Dundar M, Gartland KMA, Miertuš S (2018) Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and pre-accession EU countries (CRO, RO, B&H, SRB). Crit Rev Biotechnol 29:1–19
Dilli S, Elert N, Herrmann AM (2018) Small Bus Econ 51:293
Downes L, Mui C (2000) Unleashing the killer application: digital strategies for market dominance. Harvard Business School, Boston
Evens RP, Kaitin KI (2018) The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry—mapping biotechnology’s success. Clin Pharmacol Ther 95(5):528–32; Exp Rev Pharmacoecon Outcomes Res
Giones F, Brem A (2017) From toys to tools: the co-evolution of technological and entrepreneurial developments in the drone industry. Bus Horizons 60(6):875–884
Hager Y (2019) Medical communications: the “write” career path for you? Cold Spring Harb Perspect Biol 11(1)
Hohnen P (2017) A winning formula for sustainable chemical startups. Innov Forum 1
Horvath B, Khazami N, Ymeri P, Fogarassy C (2019) Investigating the current business model innovation trends in the biotechnology industry. J Bus Econ Manage 20(1):63–85
Joshi T (2018) The dynamics of knowledge sharing in the biotechnology industry: an Indian perspective technology innovation management review 8(1)
Kafarski P (2012) Rainbow code of biotechnology. Chemik 66(8):811–816
Kaitin KI (2010) Deconstructing the drug development process: the new face of innovation. Clin Pharmacol Ther 87(3):356–361
Katz F, Glass RI (2019) Mentorship training is essential to advancing global health research. Am J Trop Med Hyg 100(1_Suppl):1–2. https://doi.org/10.4269/ajtmh.18-0694. Accessed 14 Nov 2018
Khanna I (2012) Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug Discov Today 17
Khilji S, Mroczkowski T, Bernstein B (2006) From invention to innovation: toward developing an integrated innovation model for biotech firms. J Prod Innov Manag
Kleter GA, Kuiper HA, Kok EJ (2019) Gene-edited crops: towards a harmonized safety assessment. Trends Biotechnol
Lamb JA, Curtin JA (2019) Translational medicine: insights from interdisciplinary graduate research training. Trends Biotechnol 37(3):227–230
Lastres HMM, Sarita A (1999) Informacao e Globalizacao na Era do Conhecimento. Rio de Janeiro, Editora Campus Ltda
Maak TG, Wylie JD (2016) Medical device regulation: a comparison of the United States and the European Union. J Am Acad Orthop Surg 24(8):537–543
Meshram A, Singhal G, Bhagyawant SS, Srivastava N (2019) Chapter 28—plant-derived enzymes: a treasure for food biotechnology. In: Enzymes in food biotechnology production, applications, and future prospects, pp 483–502
Moustafa K, Makhzoum A, Trémouillaux-Guiller J (2016) Molecular farming on rescue of pharma industry for next generations. Crit Rev Biotechnol 36(5):840–850
Munos B (2009) Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 8:959–968
Munshi A (2019) Assessment of competitiveness of food-tech start-ups in India. Indian J Public Admin 65(1):201–224
Nagendran M, Riordan DP, Harbury PB, Desai TJ (2018) Automated cell-type classification in intact tissues by single-cell molecular profiling. eLife 7
Ninawe (2019) Accelerating research and education for the growth of life sciences and biotechnology. Int J Biol 4(1):12–22
Octave S, Thomas D (2009) Biorefinery: toward an industrial metabolism. Biochimie 91(6):659–664
Pessoa MG, Vespermann KAC, Paulino BN, Barcelos MCS, Pastore GM, Molina G (2019) Newly isolated microorganisms with potential application in biotechnology. Biotechnol Adv 37(2):319–339
Rohela GK, Srinivasulu Y, Rathore MS (2019) A review paper on recent trends in bio-nanotechnology: implications and potentials. Nanosci Nanotechnol Asia 9(1):12–20(9)
Segers JP (2015) J Glob Entrepr Res 5:16
Stuart TE, Ding WW (2006) When do scientists become entrepreneurs? the social structural antecedents of commercial activity in the academic life sciences. Am J Sociol 112(1):97–144
Stuart TE, Ozdemir SZ, Ding WW (2007) Vertical alliance networks: the case of university—biotechnology—pharmaceutical alliance chains. Res Policy 36(4):477–498
Tohidyan Far S, Rezaei-Moghaddam K (2019) J Glob Entrepr Res 9:23
VijayPaul PE, Sangeetha V, Deepika RG (2019) Chapter 9—emerging trends in the industrial production of chemical products by microorganisms. Recent Develop Appl Microbiol Biochem 107–125
Xu N, Wei L, Liu J (2019) Recent advances in the applications of promoter engineering for the optimization of metabolite biosynthesis. World J Microbiol Biotechnol 35:33
Zahra SA (2007) Contextualizing theory building in entrepreneurship research. J Bus Ventur 22(3):443–452
Zeng AP (2019) New bioproduction systems for chemicals and fuels: needs and new development. Biotechnol Adv S0734-9750(19)30003-5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Verma, G., Ravichandran, S. (2020). Evolution of Biotechnology as a Million Dollar Market: The Management and Commerce of a Biotech Start-up. In: Saxena, A. (eds) Biotechnology Business - Concept to Delivery. EcoProduction. Springer, Cham. https://doi.org/10.1007/978-3-030-36130-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-36130-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36129-7
Online ISBN: 978-3-030-36130-3
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)